Literature DB >> 23409733

Chloroquine cardiotoxicity mimicking connective tissue disease heart involvement.

András Vereckei1, Adám Fazakas, Timea Baló, Béla Fekete, Mária Judit Molnár, István Karádi.   

Abstract

The authors report a case of rare chloroquine cardiotoxicity mimicking connective tissue disease heart involvement in a 56-year-old woman with mixed connective tissue disease (MCTD) manifested suddenly as third degree A-V block with QT(c) interval prolongation and short torsade de pointes runs ultimately degenerating into ventricular fibrillation. Immunological tests suggested an MCTD flare, implying that cardiac arrest had resulted from myocardial involvement by MCTD. However, QT(c) prolongation is not a characteristic of cardiomyopathy caused by connective tissue disease, unless anti-Ro/SSA positivity is present, but that was not the case. Therefore, looking for another cause of QT(c) prolongation the possibility of chloroquine cardiotoxicity emerged, which the patient had been receiving for almost two years in supramaximal doses. Biopsy of the deltoid muscle was performed, because in chloroquine toxicity, specific lesions are present both in the skeletal muscle and in the myocardium, and electron microscopy revealed the accumulation of cytoplasmic curvilinear bodies, which are specific to antimalarial-induced myocyte damage and are absent in all other muscle diseases, except neuronal ceroid lipofuscinosis. Thus, the diagnosis of chloroquine cardiotoxicity was established. It might be advisable to supplement the periodic ophthalmological examination, which is currently the only recommendation for patients on long-term chloroquine therapy, with ECG screening.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23409733     DOI: 10.3109/08923973.2013.766801

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  7 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  COVID-19: treatments and the potential for cardiotoxicity.

Authors:  Sarah Maria Birkhoelzer; Elena Cowan; Kaushik Guha
Journal:  Br J Cardiol       Date:  2021-03-09

3.  Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase.

Authors:  Diego Macías Saint-Gerons; Rafael Tabarés-Seisdedos
Journal:  Eur J Clin Pharmacol       Date:  2021-05-03       Impact factor: 3.064

4.  A study of the possible factors affecting COVID-19 spread, severity and mortality and the effect of social distancing on these factors: Machine learning forecasting model.

Authors:  Hossam M Zawbaa; Ahmed El-Gendy; Haitham Saeed; Hasnaa Osama; Ahmed M A Ali; Dina Gomaa; Mona Abdelrahman; Hadeer S Harb; Yasmin M Madney; Mohamed E A Abdelrahim
Journal:  Int J Clin Pract       Date:  2021-03-08       Impact factor: 3.149

5.  Tafenoquine at therapeutic concentrations does not prolong Fridericia-corrected QT interval in healthy subjects.

Authors:  Justin A Green; Apurva K Patel; Bela R Patel; Azra Hussaini; Emma J Harrell; Mirna J McDonald; Nick Carter; Khadeeja Mohamed; Stephan Duparc; Ann K Miller
Journal:  J Clin Pharmacol       Date:  2014-04-09       Impact factor: 3.126

6.  Bacillus Calmette-Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality.

Authors:  Ahmed Osama El-Gendy; Haitham Saeed; Ahmed M A Ali; Hossam M Zawbaa; Dina Gomaa; Hadeer S Harb; Yasmin M Madney; Hasnaa Osama; Mona A Abdelrahman; Mohamed E A Abdelrahim
Journal:  Vaccine       Date:  2020-07-03       Impact factor: 3.641

Review 7.  Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.

Authors:  Margaux Louchet; Jeanne Sibiude; Gilles Peytavin; Olivier Picone; Jean-Marc Tréluyer; Laurent Mandelbrot
Journal:  Am J Obstet Gynecol MFM       Date:  2020-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.